MSC Therapy for Long COVID? The 2025 Clinical Trial Evidence
Introduction “Long COVID” (post‑acute sequelae of SARS‑CoV‑2) can persist for months with fatigue, shortness of breath, brain fog, dysautonomia (a problem with the nerves that control automatic body functions like heart rate and blood pressure) and exercise intolerance. Standard care focuses on rehabilitation and symptom control. Mesenchymal stem‑cell (MSC) therapy is being studied as a … Read more